<add><doc>
	<field name = "DATE">1-JUN-1987 09:46:27.25</field>
	<field name = "PLACES">usa</field>
	<field name = "UNKNOWN">F
f0978reute
r f BC-SCHERING-PLOUGH-SGP>   06-01 0074</field>
	<field name = "TITLE">SCHERING-PLOUGH SGP> GETS FDA APPROVAL</field>
	<field name = "DATELINE">MADISON, N.J., June 1 -</field>
	<field name = "BODY">Schering-Plough Corp said its
Elocon topical steroid for inflammatory skin disorders has been
approved for marketing by the U.S. Food and Drug Administration
in cream and ointment forms for once-daily applications.
    The company said overseas health agency registrations for
Elocon are scheduled to be submitted in a number of major
markets this year and in other areas in 1988.
 Reuter</field>
</doc></add>
